Cargando…
Pharmacogenomic and clinical data link non-pharmacokinetic metabolic dysregulation to drug side effect pathogenesis
Drug side effects cause a significant clinical and economic burden. However, mechanisms of drug action underlying side effect pathogenesis remain largely unknown. Here, we integrate pharmacogenomic and clinical data with a human metabolic network and find that non-pharmacokinetic metabolic pathways...
Autores principales: | Zielinski, Daniel C., Filipp, Fabian V., Bordbar, Aarash, Jensen, Kasper, Smith, Jeffrey W., Herrgard, Markus J., Mo, Monica L., Palsson, Bernhard O. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Pub. Group
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4468904/ https://www.ncbi.nlm.nih.gov/pubmed/26055627 http://dx.doi.org/10.1038/ncomms8101 |
Ejemplares similares
-
iAB-RBC-283: A proteomically derived knowledge-base of erythrocyte metabolism that can be used to simulate its physiological and patho-physiological states
por: Bordbar, Aarash, et al.
Publicado: (2011) -
Systems biology analysis of drivers underlying hallmarks of cancer cell metabolism
por: Zielinski, Daniel C., et al.
Publicado: (2017) -
A Multi-scale Computational Platform to Mechanistically Assess the Effect of Genetic Variation on Drug Responses in Human Erythrocyte Metabolism
por: Mih, Nathan, et al.
Publicado: (2016) -
Systems biology as an emerging paradigm in transfusion medicine
por: Yurkovich, James T., et al.
Publicado: (2018) -
A Systems Approach to Predict Oncometabolites via Context-Specific Genome-Scale Metabolic Networks
por: Nam, Hojung, et al.
Publicado: (2014)